← Evidence map

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.

Rulan Griesel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 35099526